Review



rna fragments  (New England Biolabs)


Bioz Verified Symbol New England Biolabs is a verified supplier
Bioz Manufacturer Symbol New England Biolabs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    New England Biolabs rna fragments
    Transcriptome-wide mapping and biochemical characterization of RhsP2 <t>RNA</t> recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for <t>RNase</t> T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).
    Rna Fragments, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 15907 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kinase/T4+Polynucleotide+Kinase/pmc13768812-177-9-18
    Average 99 stars, based on 15907 article reviews
    rna fragments - by Bioz Stars, 2026-11
    99/100 stars

    Images

    1) Product Images from "An RNA-targeting ADP-ribosyltransferase toxin uncouples mRNA stability from productive translation"

    Article Title: An RNA-targeting ADP-ribosyltransferase toxin uncouples mRNA stability from productive translation

    Journal: Nucleic Acids Research

    doi: 10.1093/nar/gkag1177

    Transcriptome-wide mapping and biochemical characterization of RhsP2 RNA recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for RNase T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).
    Figure Legend Snippet: Transcriptome-wide mapping and biochemical characterization of RhsP2 RNA recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for RNase T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).

    Techniques Used: Cross-linking Immunoprecipitation, Expressing, Immunoprecipitation, SDS Page, Sequencing, Analysis, Labeling, Biomarker Discovery, Modification, Binding Assay, Incubation, Purification, In Vitro, Urea-PAGE, Control, Generated, cDNA Library Assay

    Related Articles

    Polymerase Chain Reaction:

    Article Title: Biochemical and genetic dissection of the RNA-binding surface of the FinO domain of Escherichia coli ProQ.
    Article Snippet: Primers were used in a PCR with 2× Phusion Master Mix (New England Biolabs) and the appropriate parent plasmid: pKB955 (pBrα-ProQΔCTD) for Y70X and R80X libraries and pSP144 (pBrα-ProQΔCTD-R80K) for the R80K multisite compensatory libraries. .. For Y70X and R80X libraries, PCR products were Kinase–Ligase–DpnI (KLD) treated in 10 μL reactions containing 1 μL PCR Product, 1 μL T4 DNA Ligase (New England Biolabs), 1 μL T4 DNA Ligase buffer (New England Biolabs), 1 μL T4 polynucleotide kinase (PNK; New England Biolabs), 1 μL DpnI (New England Biolabs), and 5 μLMilliQwater. .. For themultisite-ProQ-R80K libraries, a commercial KLDmixture was used according to themanufacturer’s instructions (New England Biolabs).

    Article Title: Crystal structure and activity of a de novo enzyme, ferric enterobactin esterase Syn-F4.
    Article Snippet: .. The PCR products were treated with a kinase–ligase–DpnI (KLD) mix (New England BioLabs.) ..

    Article Title: The Role of Heparan Sulfate in CCL26-Induced Eosinophil Chemotaxis
    Article Snippet: Using huCCL26 as a template, seven CCL26 “knock-out” mutants (decreased binding affinity to GAGs) were prepared by site-directed mutagenesis with the help of complementary oligonucleotide pairs encoding the intended mutations (see ), a Q5 high-fidelity polymerase (NEB, Ipswich, MA, USA), and dNTPs (NEB). .. After using Eppendorf’s mastercycler gradient for PCR, the original plasmid was digested with Dpn1 (NEB), and the remaining modified ones were treated with kinase (NEB) and ligase (NEB) enzymes as per the manufacturer’s instructions. .. The plasmids were then transformed into E. coli Top10 for plasmid amplification and subsequently isolated using Qiagen Midiprep kits according to the manufacturer’s directions.

    Plasmid Preparation:

    Article Title: The Role of Heparan Sulfate in CCL26-Induced Eosinophil Chemotaxis
    Article Snippet: Using huCCL26 as a template, seven CCL26 “knock-out” mutants (decreased binding affinity to GAGs) were prepared by site-directed mutagenesis with the help of complementary oligonucleotide pairs encoding the intended mutations (see ), a Q5 high-fidelity polymerase (NEB, Ipswich, MA, USA), and dNTPs (NEB). .. After using Eppendorf’s mastercycler gradient for PCR, the original plasmid was digested with Dpn1 (NEB), and the remaining modified ones were treated with kinase (NEB) and ligase (NEB) enzymes as per the manufacturer’s instructions. .. The plasmids were then transformed into E. coli Top10 for plasmid amplification and subsequently isolated using Qiagen Midiprep kits according to the manufacturer’s directions.

    Article Title: The transcription factors Creb1 and CEBPB regulate Sox9 promoter activity in TM4 Sertoli cells.
    Article Snippet: In Sertoli cells, the Sox9 gene is essential for testicular development and normal spermatogenesis.. SOX9 is critical for postnatal Sertoli cells differentiation and proliferation in the testis.. However, the molecular mechanisms that specifically regulate its expression are not entirely understood.

    Modification:

    Article Title: The Role of Heparan Sulfate in CCL26-Induced Eosinophil Chemotaxis
    Article Snippet: Using huCCL26 as a template, seven CCL26 “knock-out” mutants (decreased binding affinity to GAGs) were prepared by site-directed mutagenesis with the help of complementary oligonucleotide pairs encoding the intended mutations (see ), a Q5 high-fidelity polymerase (NEB, Ipswich, MA, USA), and dNTPs (NEB). .. After using Eppendorf’s mastercycler gradient for PCR, the original plasmid was digested with Dpn1 (NEB), and the remaining modified ones were treated with kinase (NEB) and ligase (NEB) enzymes as per the manufacturer’s instructions. .. The plasmids were then transformed into E. coli Top10 for plasmid amplification and subsequently isolated using Qiagen Midiprep kits according to the manufacturer’s directions.

    Amplification:

    Article Title: Use of Epivolve phage display to generate a monoclonal antibody with opsonic activity directed against a subdominant epitope on extracellular loop 4 of Treponema pallidum BamA (TP0326)
    Article Snippet: The Pf Trx BamA/ECL4 Mexico A construct was generated by reverse PCR using Q5 Hot Start High-Fidelity DNA polymerase (New England Biolabs, Inc.) in a 25-μl reaction containing 100 ng of Pf Trx BamA/ECL4 (Nichols) plasmid and Pf Trx BamA/ECL4 MexA-FW and MexA-RV primers (see ). .. The resulting amplicon was self-ligated using Kinase, Ligase & Dpnl Enzyme Mix (New England Biolabs, Inc.), transformed into Top10 cells, and plated on LB containing kanamycin. ..

    Transformation Assay:

    Article Title: Use of Epivolve phage display to generate a monoclonal antibody with opsonic activity directed against a subdominant epitope on extracellular loop 4 of Treponema pallidum BamA (TP0326)
    Article Snippet: The Pf Trx BamA/ECL4 Mexico A construct was generated by reverse PCR using Q5 Hot Start High-Fidelity DNA polymerase (New England Biolabs, Inc.) in a 25-μl reaction containing 100 ng of Pf Trx BamA/ECL4 (Nichols) plasmid and Pf Trx BamA/ECL4 MexA-FW and MexA-RV primers (see ). .. The resulting amplicon was self-ligated using Kinase, Ligase & Dpnl Enzyme Mix (New England Biolabs, Inc.), transformed into Top10 cells, and plated on LB containing kanamycin. ..

    other:

    Article Title: Engineered microorganisms for the production of intermediates and final products
    Article Snippet: This fragment was then assembled into pCJ074 digested with NotI (6905). pCJ125 Deletion of galC and galB was amplified from P. putida KT2440 genomic DNA with integration of the tac primer pair oCJ626/oCJ627 (855 bp) and assembled into pCJ124 promoter upstream of digested with SpeI (7,572 bp). galBD n P. putida KT2440 and strains derived from it pJE365 Deletion of gcd in The 5′ targeting region was amplified from P. putida KT2440 genomic P. putida KT2440 and DNA with primer pair pJE365_5′_F/pJE365_5′_R (751 bp) while the 3′ strains derived from it targeting region was amplified from P. putida KT2440 genomic DNΔ with primer pair pJE365_3′_F/pJE365_3′_R (748 bp) and these fragments were assembled into pK18mobsacB linearized with by digestion with restriction enzymes XbaI and HindIII (5695 bp). pSN2 Replacement of pykA pCJ117 was amplified linearly with oSN3 and oSN4 (8905 bp) to include with the Ptac:aroG- aroG-D146N and AsbF but exclude aroY:ecdB and treated with NEB D146N:asbF cassette in KLD Enzyme Mix (New England Biolabs), which includes kinase, ligase P. putida KT2440 and and DpnI enzymes to phosphorylate and circularize the PCR product and strains derived from it digest the template, according to the manufacturer's instructions.

    Article Title: Functional and structural analyses reveal that a dual domain sialidase protects bacteria from complement killing through desialylation of complement factors.
    Article Snippet: The subsequent PCR products were treated with a proprietary mix of kinase, ligase, and DpnI enzymes (New England Biolabs), and then transformed into NEB5α for plasmid purification.



    Similar Products

    99
    New England Biolabs rna fragments
    Transcriptome-wide mapping and biochemical characterization of RhsP2 <t>RNA</t> recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for <t>RNase</t> T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).
    Rna Fragments, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kinase/T4+Polynucleotide+Kinase/pmc13768812-177-9-18
    Average 99 stars, based on 1 article reviews
    rna fragments - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc amp activated protein kinase α ampkα
    Transcriptome-wide mapping and biochemical characterization of RhsP2 <t>RNA</t> recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for <t>RNase</t> T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).
    Amp Activated Protein Kinase α Ampkα, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kinase/AMPKalpha+Antibody/pmc12811471-130-16-22
    Average 97 stars, based on 1 article reviews
    amp activated protein kinase α ampkα - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc phosphorylated adenosine monophosphate activated protein kinase
    Transcriptome-wide mapping and biochemical characterization of RhsP2 <t>RNA</t> recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for <t>RNase</t> T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).
    Phosphorylated Adenosine Monophosphate Activated Protein Kinase, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kinase/Phospho-AMPKalpha+(Thr172)+Antibody/pmc12811436-71-41-48
    Average 96 stars, based on 1 article reviews
    phosphorylated adenosine monophosphate activated protein kinase - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc protein kinase b
    Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.
    Protein Kinase B, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kinase/pmc12816905-99-21-27
    Average 86 stars, based on 1 article reviews
    protein kinase b - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc protein kinase b akt
    miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) <t>AKT,</t> and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.
    Protein Kinase B Akt, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kinase/Akt+Antibody/pmc12811471-130-43-48
    Average 99 stars, based on 1 article reviews
    protein kinase b akt - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    96
    Tocris rho kinase inhibitor y 27 632
    miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) <t>AKT,</t> and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.
    Rho Kinase Inhibitor Y 27 632, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kinase/Y-27632+dihydrochloride/pmc13768266-53-10-15
    Average 96 stars, based on 1 article reviews
    rho kinase inhibitor y 27 632 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    95
    BPS Bioscience kinase glo max luminescent assay kit
    miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) <t>AKT,</t> and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.
    Kinase Glo Max Luminescent Assay Kit, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kinase/EGFR+Kinase+Assay+Kit/pmc13752819-417-22-27
    Average 95 stars, based on 1 article reviews
    kinase glo max luminescent assay kit - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    BPS Bioscience promising cytotoxic compounds
    miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) <t>AKT,</t> and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.
    Promising Cytotoxic Compounds, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kinase/VEGFR2+(KDR)+Kinase+Assay+Kit/pmc13752819-417-2-13
    Average 95 stars, based on 1 article reviews
    promising cytotoxic compounds - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    99
    New England Biolabs reverse oligonucleotides
    miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) <t>AKT,</t> and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.
    Reverse Oligonucleotides, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kinase/T4+Polynucleotide+Kinase/pm42977768-372-2-12
    Average 99 stars, based on 1 article reviews
    reverse oligonucleotides - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    95
    BPS Bioscience egfr assay kit
    miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) <t>AKT,</t> and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.
    Egfr Assay Kit, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kinase/EGFR+Kinase+Assay+Kit/pmc13764303-230-7-10
    Average 95 stars, based on 1 article reviews
    egfr assay kit - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    Image Search Results


    Transcriptome-wide mapping and biochemical characterization of RhsP2 RNA recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for RNase T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).

    Journal: Nucleic Acids Research

    Article Title: An RNA-targeting ADP-ribosyltransferase toxin uncouples mRNA stability from productive translation

    doi: 10.1093/nar/gkag1177

    Figure Lengend Snippet: Transcriptome-wide mapping and biochemical characterization of RhsP2 RNA recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for RNase T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).

    Article Snippet: Following RNase I treatment and stringent washing, the bead-bound RNA fragments were treated with T4 Polynucleotide Kinase (PNK, NEB) to coordinate the RNA ends for ligation.

    Techniques: Cross-linking Immunoprecipitation, Expressing, Immunoprecipitation, SDS Page, Sequencing, Analysis, Labeling, Biomarker Discovery, Modification, Binding Assay, Incubation, Purification, In Vitro, Urea-PAGE, Control, Generated, cDNA Library Assay

    Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.

    Journal: Journal of Sport and Health Science

    Article Title: Weightlifting outperforms voluntary wheel running for improving adiposity and insulin sensitivity in obese mice

    doi: 10.1016/j.jshs.2025.101100

    Figure Lengend Snippet: Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.

    Article Snippet: Primary antibodies used for analysis were from Cell Signaling Technologies (Danvers, MA, USA) and diluted 1:1000 unless otherwise stated as follows: protein kinase B (Akt; 1:500; #4691; Cell Signaling Technologies), phospho-Akt (pAkt) S473 (1:500; #9271; Cell Signaling Technologies), Ubiquitin (#3933; Cell Signaling Technologies), microtubule-associated protein light chain 3 (LC3 II/I; #4018; Cell Signaling Technologies), cytochrome c oxidase subunit 4(COX4; #11967; Cell Signaling Technologies), Akt substrate 160 (AS160 S318; #8619; Cell Signaling Technologies), AS160 T642 (#8881; Cell Signaling Technologies), eukaryotic translation initiation factor 4E binding protein (4E-BP1; #9452; Cell Signaling Technologies), and glyceraldehyde 3 phosphate dehydrogenase (GAPDH; #2118; Cell Signaling Technologies).

    Techniques: Phospho-proteomics, Injection, Western Blot, Muscles, Ubiquitin Proteomics, Staining, Binding Assay

    miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) AKT, and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.

    Journal: Journal of Sport and Health Science

    Article Title: Exercise training-induced extracellular miR-136-3p modulates glucose uptake and myogenesis through targeting of NRDC in human skeletal muscle

    doi: 10.1016/j.jshs.2025.101091

    Figure Lengend Snippet: miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) AKT, and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.

    Article Snippet: Membranes were incubated with primary antibodies directed to NRDC (sc-137199; Santa Cruz Biotechnology, Dallas, TX, USA), AMP-activated protein kinase α (AMPKα) (#2532; Cell Signaling Technology, Danvers, MA, USA), Akt substrate of 160 kDa (AS160) (#2670; Cell Signaling Technology), phospho-AS160 (#8730; Cell Signaling Technology), protein kinase B (AKT) (#9272; Cell Signaling Technology), phospho-AKT (Ser473) (#9271; Cell Signaling Technology), or puromycin (MABE343; Merck Burlington, MA, USA).

    Techniques: Protein-Protein interactions, Expressing, Transfection, Western Blot, Incubation, Staining, Control, Negative Control